Article Text
Review series
α1-Antitrypsin deficiency · 5: Intravenous augmentation therapy: current understanding
Abstract
The biochemical and clinical efficacy of intravenous augmentation therapy in α1-antitrypsin deficiency is reviewed, adverse events experienced with this treatment are considered, and its cost effectiveness is discussed.
- α1-antitrypsin deficiency
- augmentation therapy